These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 1394027

  • 1. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M, Guelfi JD.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [Abstract] [Full Text] [Related]

  • 2. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [Abstract] [Full Text] [Related]

  • 3. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y, Guelfi JD.
    Acta Psychiatr Scand Suppl; 1990 Feb; 360():18-23. PubMed ID: 2248063
    [Abstract] [Full Text] [Related]

  • 5. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP, Gleiter CH, Möller HJ.
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F, Wolfersdorf M.
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [Abstract] [Full Text] [Related]

  • 7. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M, Nardi AE, Mundim FD, Alves AB.
    J Neural Transm Suppl; 1989 May; 28():65-75. PubMed ID: 2794994
    [Abstract] [Full Text] [Related]

  • 8. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [Abstract] [Full Text] [Related]

  • 9. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 10. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M, Biziére K, Schmid-Burgk W, Amrein R.
    J Neural Transm Suppl; 1989 Jan; 28():77-89. PubMed ID: 2677244
    [Abstract] [Full Text] [Related]

  • 11. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP, Ahmed SK, Kin NM.
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [Abstract] [Full Text] [Related]

  • 12. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R, Le Houezec J, Payan C, Mikkelsen H, Fermanian J, Millet V, Dufour H.
    Psychiatry Res; 1998 Jul 13; 79(3):267-75. PubMed ID: 9704873
    [Abstract] [Full Text] [Related]

  • 13. Moclobemide--placebo-controlled trials.
    Silverstone T.
    Int Clin Psychopharmacol; 1993 Jan 13; 7(3-4):133-6. PubMed ID: 8468433
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
    Bizière K, Berger M.
    Acta Psychiatr Scand Suppl; 1990 Jan 13; 360():59-60. PubMed ID: 2248074
    [Abstract] [Full Text] [Related]

  • 15. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.
    Acta Psychiatr Scand Suppl; 1990 Jan 13; 360():48-9. PubMed ID: 2248070
    [Abstract] [Full Text] [Related]

  • 16. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.
    Clin Neuropharmacol; 1993 Jan 13; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [Abstract] [Full Text] [Related]

  • 17. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M, Nardi AE, Figueira IL, Stabl M.
    Acta Psychiatr Scand Suppl; 1990 Jan 13; 360():24-8. PubMed ID: 2123366
    [Abstract] [Full Text] [Related]

  • 18. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M, Cattiez P, Franck G, Burton P, Defleur J, Hermans W, Roelandts A, Wolfrum C, Berger M, Hellstern K.
    Acta Psychiatr Scand Suppl; 1990 Jan 13; 360():50-1. PubMed ID: 2248071
    [Abstract] [Full Text] [Related]

  • 19. Reversible monoamine oxidase-A inhibitors in panic disorder.
    Bakish D, Saxena BM, Bowen R, D'Souza J.
    Clin Neuropharmacol; 1993 Jan 13; 16 Suppl 2():S77-82. PubMed ID: 8313401
    [Abstract] [Full Text] [Related]

  • 20. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
    Lecrubier Y, Pedarriosse AM, Payan C, Schmid-Burgk W, Stabl M.
    Acta Psychiatr Scand; 1995 Oct 13; 92(4):260-5. PubMed ID: 8848950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.